Showing results (41-50 of 408) with videos related to
Sort By:
Pageof 41
Genome Biology|October 16, 2014
Toward better benchmarking: challenge-based methods assessment in cancer genomicsPaul C Boutros, Adam A Margolin, Joshua M Stuart, et al.BMC Bioinformatics|November 5, 2018
A comparative study of survival models for breast cancer prognostication revisited: the benefits of multi-gene modelsMichal R Grzadkowski, Dorota H Sendorek, Christine P'ng, et al.Cancer Research|November 30, 2022
Single-Cell Analysis in Lung Adenocarcinoma Implicates RNA Editing in Cancer Innate Immunity and Patient PrognosisTracey W Chan, Jack P Dodson, Jaron Arbet, et al.Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experienceM V Bluthgen, C Boutros, F Fayard, et al.Cancer Research|October 3, 2018
Sex Differences in Cancer Driver Genes and BiomarkersConstance H Li, Syed Haider, Yu-Jia Shiah, et al.Bioinformatics (Oxford, England)|September 11, 2016
Nanocall: an open source basecaller for Oxford Nanopore sequencing dataMatei David, L J Dursi, Delia Yao, et al.Toxicology and Applied Pharmacology|February 24, 2015
Sex-related differences in murine hepatic transcriptional and proteomic responses to TCDDStephenie D Prokopec, John D Watson, Jamie Lee, et al.Journal of the National Cancer Institute|June 2, 2016
Current and Evolving Methods to Visualize Biological Data in Cancer ResearchPuey Ling Chia, Craig Gedye, Paul C Boutros, et al.BMC Genomics|September 18, 2008
Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mousePaul C Boutros, Rui Yan, Ivy D Moffat, et al.BMC Genomics|April 28, 2010
Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicitiesIvy D Moffat, Paul C Boutros, Hanbo Chen, et al.Pageof 41